Pfizer Unusual Options Activity For February 21
Portfolio Pulse from Benzinga Insights
Pfizer (NYSE:PFE) has seen unusual options activity, with over 14 transactions valued at $1,147,738, indicating a bullish sentiment among significant investors targeting a price range of $22.5 to $30.0 over the next three months. The mean open interest for Pfizer options is 14,039.29 with a total volume of 23,475.00. The largest trades observed suggest a bullish outlook, with notable trades including puts and calls with expiration dates ranging from 2024 to 2025 and strike prices around $25 to $26. Pfizer, a leading pharmaceutical company with annual sales close to $50 billion, has its stock currently trading at $27.63, showing a 0.14% increase. The RSI indicates a neutral position, and an earnings announcement is expected in 69 days. An analyst from Cantor Fitzgerald has set a price target of $45, downgrading the stock to Overweight.
February 21, 2024 | 7:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer's unusual options activity and bullish sentiment among investors suggest a positive short-term outlook. The stock's current neutral RSI and upcoming earnings announcement could influence its price movement.
The significant options activity, particularly the bullish sentiment reflected in the trades, suggests investor confidence in Pfizer's short-term performance. The neutral RSI indicates that the stock is not currently overbought or oversold, providing a stable ground for potential growth. The upcoming earnings announcement could serve as a catalyst for price movement, while the analyst rating from Cantor Fitzgerald supports a positive outlook.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100